Oncology & Cancer

Biomarker predicts bowel cancer recurrence

A biomarker in the blood of patients with bowel cancer may provide valuable insight into the risk of cancer relapse after surgery and the effectiveness of chemotherapy.

Oncology & Cancer

Margin-positive surgery still beneficial in pancreatic cancer

(HealthDay)—For patients with stage II pancreatic cancer, attempted surgery with margin-positive resection may offer survival benefit over chemotherapy alone, according to a study published online March 26 in the Journal ...

Medical research

Improving survival in pancreatic cancer

Nagoya University researchers and colleagues in Japan have uncovered a molecular pathway that enhances chemotherapy resistance in some pancreatic cancer patients. Targeting an RNA to interrupt its activity could improve patient ...

Oncology & Cancer

Study: New approach may boost prostate cancer immunotherapies

Researchers have discovered a new way to transform the tissues surrounding prostate tumors to help the body's immune cells fight the cancer. The discovery, made in human and mouse cells and in laboratory mice, could lead ...

page 12 from 40